What's new

Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive

Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive

Mar 11, 2025 - 13:43
 0
Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive
Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive
Read More

Tags:

Previous Article

UltiMaker boosts 3D printing speeds and productivity with UltiMaker S8

Next Article

Stella McCartney revenue falls in tough year

Related Posts

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Product-specific bioequivalence guidance

Product-specific bioequivalence guidance

Feb 10, 2025  0